Default company panoramic image
41502d39 54f7 4285 850a fa3f77538984

SMaRT Therapeutics

SMaRT Therapeutics focuses on the discovery of small-molecule drugs that treat diseases by selectively targeting and modulating RNA.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Jupiter, FL, USA
  • Currency USD
  • Founded January 2011
  • Website

Company Summary

SMaRT Therapeutics targets RNA for drugs. The company has received $9.6 million in grant funds from Scripps and NIH and is looking for additional investment to take its three most advanced drug candidates into clinical trials (myotonic dystrophy type I currently in bioanalytical testing, and myotonic dystrophy type II and fragile X syndrome, both in toxicology testing).

Previous Investors

  • Default avatar
    National Institutes of HEalth
    Default avatar
    SCripps Research
    Default avatar
    State University of NY